Literature DB >> 16354630

A rationale for therapeutic decision-making in chalazia.

Upreet Dhaliwal1, Arati Bhatia.   

Abstract

BACKGROUND: Cytologically, a chalazion may be either a mixed-cell or a suppurating granuloma. Treatment includes incision & curettage or intralesional steroid injection. The choice of treatment is based on clinical experience.
OBJECTIVE: To determine whether the cytological type of chalazion has any bearing on its response to treatment.
MATERIALS AND METHODS: Prospective study of 62 clinically suspected cases of chalazia subjected to fine-needle aspiration cytology followed by either incision & curettage or intralesional steroid injection. The outcome measure was the size of the residual lesion at one week and one month post-intervention. The relationship between cytology and age, duration, size of lesion, type of treatment and response was analyzed by means of Student's t-test, the chi-square test and discriminant analysis.
RESULTS: Thirty-five (56.5%) patients underwent incision & curettage while 27 (43.5%) received intralesional steroid injections. Cytology revealed mixed-cell granuloma in 41 (66.1%) and suppurating granuloma in 21 (33.9%) of the lesions. Patients aged > or = 35.1 years, lesions with duration > or = 8.5 months, and lesion sizes > or = 11.4 mm (correctly classified in 66.1%, 66.7% and 71.0% of the cases, respectively) were likely to have/be suppurating granulomas. Mixed-cell granulomas responded equally well to the two therapeutic modalities, while suppurating granulomas responded significantly better to incision & curettage (p = 0.008).
CONCLUSION: Mixed-cell granulomas may be treated by either of the two therapeutic modalities. However, suppurating granulomas should be treated by incision & curettage. Incision & curettage should also be the procedure of choice in patients > or = 35.1 years of age, lesions with duration > or = 8.5 months, and lesions > or = 11.4 mm in size.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16354630     DOI: 10.1080/01676830590946907

Source DB:  PubMed          Journal:  Orbit        ISSN: 0167-6830


  3 in total

1.  Conservative therapy for chalazia: is it really effective?

Authors:  Albert Y Wu; Kalla A Gervasio; Kellie N Gergoudis; Chen Wei; James H Oestreicher; John T Harvey
Journal:  Acta Ophthalmol       Date:  2018-01-16       Impact factor: 3.761

2.  Effects of chalazion and its treatments on the meibomian glands: a nonrandomized, prospective observation clinical study.

Authors:  Junping Li; Dongping Li; Na Zhou; Mengying Qi; Yanzhu Luo; Yuhong Wang
Journal:  BMC Ophthalmol       Date:  2020-07-11       Impact factor: 2.209

3.  A prospective randomized study comparing incision and curettage with injection of triamcinolone acetonide for chronic chalazia.

Authors:  Reza Nabie; Hadi Soleimani; Leila Nikniaz; Shalaleh Raoufi; Elmira Hassanpour; Shokooh Mamaghani; Erfan Bahremani
Journal:  J Curr Ophthalmol       Date:  2019-05-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.